BioLife Plasma Services
The Global Regulatory Labeling Strategy Lead (Associate Director) for Plasma-Derived Therapies drives regulatory labeling strategy and lifecycle management for the business unit. This role provides strategic insight and guidance to internal stakeholders to ensure successful development and maintenance of pharmaceutical drug and device labeling. The position involves formulating innovative regulatory strategies, leading cross-functional teams, and ensuring compliance with global regulatory requirements.
Headquarters
Bannockburn, Illinois, United States
Company Size
5001-10000 employees
BioLife Plasma Services operates a network of plasma collection centers that collect donated human plasma used to manufacture life‑saving plasma‑derived therapies. The company focuses on donor safety and convenience, offering screening, regulated collection procedures, appointment scheduling, and compensation/rewards to encourage repeat donations. BioLife partners with biopharmaceutical manufacturers and maintains rigorous quality and regulatory standards to supply plasma for treatments such as immune deficiencies, bleeding disorders, and other therapeutic uses.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for BioLife Plasma Services.
Associate Director, Global Labeling Lead (REMOTE)
Takeda Pharmaceuticals Korea Co., Ltd.
Global Labeling Lead
Takeda Pharmaceutical Company Limited
Senior Manager, Global Labeling Strategy
Bristol Myers Squibb
Associate Director, Labeling Strategy
Travere Therapeutics
Director Core Labeling Strategy
Viatris
Regulatory Affairs Consultant - Labelling Strategy (home or office based)
Parexel